vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Stride, Inc. (LRN). Click either name above to swap in a different company.

Stride, Inc. is the larger business by last-quarter revenue ($629.9M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). Stride, Inc. runs the higher net margin — 14.1% vs -10.1%, a 24.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.7%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 6.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Stride, Inc. is a for-profit education company that provides online and blended education programs. Stride, Inc. is an education management organization (EMO) that provides online education designed as an alternative to traditional "brick and mortar" education for public school students from kindergarten to 12th grade, as well as career learning programs. As of 2012, publicly traded Stride, Inc. was the largest EMO in terms of enrollment.

CLOV vs LRN — Head-to-Head

Bigger by revenue
LRN
LRN
1.3× larger
LRN
$629.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+42.0% gap
CLOV
44.7%
2.7%
LRN
Higher net margin
LRN
LRN
24.2% more per $
LRN
14.1%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
6.9%
LRN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
LRN
LRN
Revenue
$487.7M
$629.9M
Net Profit
$-49.3M
$88.5M
Gross Margin
Operating Margin
-10.1%
20.5%
Net Margin
-10.1%
14.1%
Revenue YoY
44.7%
2.7%
Net Profit YoY
-123.2%
8.5%
EPS (diluted)
$1.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
LRN
LRN
Q3 26
$629.9M
Q4 25
$487.7M
$631.3M
Q3 25
$496.6M
$620.9M
Q2 25
$477.6M
$653.6M
Q1 25
$462.3M
$613.4M
Q4 24
$337.0M
$587.2M
Q3 24
$331.0M
$551.1M
Q2 24
$356.3M
Net Profit
CLOV
CLOV
LRN
LRN
Q3 26
$88.5M
Q4 25
$-49.3M
$99.5M
Q3 25
$-24.4M
$68.8M
Q2 25
$-10.6M
$51.3M
Q1 25
$-1.3M
$99.3M
Q4 24
$-22.1M
$96.4M
Q3 24
$-9.2M
$40.9M
Q2 24
$7.4M
Gross Margin
CLOV
CLOV
LRN
LRN
Q3 26
Q4 25
41.1%
Q3 25
39.0%
Q2 25
36.6%
Q1 25
40.6%
Q4 24
40.8%
Q3 24
24.5%
39.2%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
LRN
LRN
Q3 26
20.5%
Q4 25
-10.1%
23.3%
Q3 25
-4.9%
11.1%
Q2 25
-2.2%
8.7%
Q1 25
-0.3%
21.3%
Q4 24
-6.4%
21.3%
Q3 24
-2.7%
8.6%
Q2 24
2.0%
Net Margin
CLOV
CLOV
LRN
LRN
Q3 26
14.1%
Q4 25
-10.1%
15.8%
Q3 25
-4.9%
11.1%
Q2 25
-2.2%
7.9%
Q1 25
-0.3%
16.2%
Q4 24
-6.6%
16.4%
Q3 24
-2.8%
7.4%
Q2 24
2.1%
EPS (diluted)
CLOV
CLOV
LRN
LRN
Q3 26
$1.93
Q4 25
$2.12
Q3 25
$1.40
Q2 25
$0.96
Q1 25
$2.02
Q4 24
$2.03
Q3 24
$0.94
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
LRN
LRN
Cash + ST InvestmentsLiquidity on hand
$78.3M
$614.0M
Total DebtLower is stronger
$417.6M
Stockholders' EquityBook value
$308.7M
$1.6B
Total Assets
$541.0M
$2.4B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
LRN
LRN
Q3 26
$614.0M
Q4 25
$78.3M
$625.7M
Q3 25
$715.1M
Q2 25
$985.3M
Q1 25
$723.7M
Q4 24
$194.5M
$717.5M
Q3 24
$288.0M
$522.2M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
LRN
LRN
Q3 26
$417.6M
Q4 25
$417.2M
Q3 25
$416.8M
Q2 25
$416.3M
Q1 25
$415.9M
Q4 24
$415.5M
Q3 24
$415.1M
Q2 24
Stockholders' Equity
CLOV
CLOV
LRN
LRN
Q3 26
$1.6B
Q4 25
$308.7M
$1.5B
Q3 25
$340.9M
$1.5B
Q2 25
$344.2M
$1.5B
Q1 25
$336.1M
$1.4B
Q4 24
$341.1M
$1.3B
Q3 24
$342.2M
$1.2B
Q2 24
$324.9M
Total Assets
CLOV
CLOV
LRN
LRN
Q3 26
$2.4B
Q4 25
$541.0M
$2.3B
Q3 25
$559.7M
$2.3B
Q2 25
$575.0M
$2.3B
Q1 25
$583.7M
$2.2B
Q4 24
$580.7M
$2.1B
Q3 24
$653.0M
$2.0B
Q2 24
$674.2M
Debt / Equity
CLOV
CLOV
LRN
LRN
Q3 26
0.25×
Q4 25
0.27×
Q3 25
0.27×
Q2 25
0.28×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.34×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
LRN
LRN
Operating Cash FlowLast quarter
$-66.9M
$117.0M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.32×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
LRN
LRN
Q3 26
$117.0M
Q4 25
$-66.9M
$91.8M
Q3 25
$12.1M
$-195.8M
Q2 25
$5.4M
$298.3M
Q1 25
$-16.3M
$53.1M
Q4 24
$34.8M
$223.4M
Q3 24
$50.0M
$-142.0M
Q2 24
$44.8M
Free Cash Flow
CLOV
CLOV
LRN
LRN
Q3 26
Q4 25
$-69.0M
$91.6M
Q3 25
$11.4M
$-196.1M
Q2 25
$4.8M
$297.9M
Q1 25
$-16.5M
$52.9M
Q4 24
$33.3M
$222.9M
Q3 24
$49.6M
$-142.7M
Q2 24
$44.4M
FCF Margin
CLOV
CLOV
LRN
LRN
Q3 26
Q4 25
-14.1%
14.5%
Q3 25
2.3%
-31.6%
Q2 25
1.0%
45.6%
Q1 25
-3.6%
8.6%
Q4 24
9.9%
38.0%
Q3 24
15.0%
-25.9%
Q2 24
12.5%
Capex Intensity
CLOV
CLOV
LRN
LRN
Q3 26
Q4 25
0.4%
0.0%
Q3 25
0.1%
0.0%
Q2 25
0.1%
0.1%
Q1 25
0.0%
0.0%
Q4 24
0.5%
0.1%
Q3 24
0.1%
0.1%
Q2 24
0.1%
Cash Conversion
CLOV
CLOV
LRN
LRN
Q3 26
1.32×
Q4 25
0.92×
Q3 25
-2.85×
Q2 25
5.81×
Q1 25
0.53×
Q4 24
2.32×
Q3 24
-3.47×
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

LRN
LRN

General Education$357.5M57%
Middle - High School$259.5M41%
Adult$12.9M2%

Related Comparisons